A study using wearable devices to manage Long COVID symptoms
Official title: The Long COVID-19 Wearable Device Study
Run by Scripps Translational Science Institute · NCT05741112 · Data updated 2026-11-12
This study is testing if using wearable devices can help people with Long COVID manage their symptoms and improve their quality of life.
Quick facts
| Study type | Interventional |
|---|---|
| Ages | 18 Years and up |
| Sex | All |
| Enrollment | 100500 (estimated) |
| Sponsor | Scripps Translational Science Institute Academic / other |
| Locations | 1 site (La Jolla, California) |
| Status | Recruiting |
| Started | November 16, 2023 |
| Main results expected | December 1, 2025 |
| Study ends | December 1, 2025 |
| Registry record updated | May 11, 2025 |
| Trial ID | NCT05741112 on ClinicalTrials.gov |
Is this trial a fit for you?
✓Likely a good fit
Ideal candidates include adults diagnosed with Long COVID, ME/CFS, or POTS who are interested in using wearable technology for symptom management.
✕Probably not a fit
Patients without a diagnosis of Long COVID, ME/CFS, or POTS, or those not interested in using wearable devices may not benefit from this study.
A plain-English reading of the study's rules. Only the study team can confirm whether you qualify.
What this trial studies
This study aims to better understand Long COVID by collecting data from individuals who either own wearable devices or are provided with one. Participants will be randomized into two groups: one will share data from their existing devices while receiving educational materials, and the other will receive a wearable device along with pacing education. The goal is to analyze the data and survey responses to improve symptom management and quality of life for those affected by Long COVID and related conditions. The study will include up to 100,000 participants, with a focus on post-exertional malaise.
Why it matters
Potential benefit: If successful, this study could provide valuable insights and tools for managing Long COVID symptoms, potentially improving patients' quality of life.
How similar studies have gone: Other studies utilizing wearable devices for chronic condition management have shown promise, suggesting this approach may be effective.
Who can join: the full rules
Show full inclusion / exclusion criteria
Inclusion Criteria: * Is at least 18 years old. * Has a self/and or physician diagnosis of: * Long COVID (based on the WHO working definition), * ME/CFS (myalgic encephalomyelitis / chronic fatigue syndrome, self-diagnosis based on IOM criteria), and/or * POTS (Postural Orthostatic Tachycardia Syndrome). * Is interested in tools to manage ME/CFS, POTS, and/or Long COVID symptoms. * Owns a wearable device they are willing to use for this study or does not own a device and agrees to utilize a study-provided one. * Agrees to wear the device throughout the study period, share the data with the study, and sync data at least weekly. * Has access to a smartphone or tablet to enable syncing wearable data and viewing device feedback. * Agrees to disclose involvement in other ME/CFS, POTS, and/or Long COVID interventions such as medical treatment, self-management, and other interventional studies. * Agrees to complete at least 75% of the study surveys. Exclusion Criteria: * As long as they meet inclusion there is no exclusion
Where it's running
-
Scripps Research
La Jolla, California, United States Recruiting
Study contacts
- Study coordinator: Andrea Goosen
- Email: agoosen@scripps.edu
- Phone: 0000000000
Similar studies
Other studies for the same condition or treatment. Recruiting studies are listed first.
-
Using Lumbrokinase to treat Long Covid, Lyme Disease, and Chronic Fatigue Syndrome
This study is testing if a treatment called Lumbrokinase can help adults with Long Covid, Lyme Disease, and Chronic Fatigue Syndrome feel better and improve their quality of life.
-
Long COVID relief through learning mindfulness
This study will try an 8-week online recorded mindfulness program to see if it reduces stress and Long COVID symptoms in adults who continue their usual care.
-
Transcranial Direct Current Stimulation for Long COVID with Headaches and Chronic Pain
This study tests whether applying mild brain stimulation (tDCS) can help people with long COVID who have headaches, migraines, and ongoing pain.
-
A 3-day course for Chronic Fatigue Syndrome/Myalgic Encephalomyelitis
This study is testing if a 3-day program called the Lightning Process can help adults with Chronic Fatigue Syndrome feel better and improve their daily lives.
-
A platform for collecting health data on ME/CFS and Long Covid
This study is trying to collect health information from adults with ME/CFS and Long Covid to help researchers better understand these conditions and improve future treatments.
-
Whole-body Cryotherapy for Fatigue in ME/CFS, Fibromyalgia, Long COVID
This study tests whether brief, repeated exposure to extreme cold can help reduce fatigue and related symptoms in adults with ME/CFS, fibromyalgia, or Long COVID compared to healthy controls.
How to take part
- Review the eligibility criteria above with your treating physician.
- Check the official listing on ClinicalTrials.gov for the latest contact details and recruitment status.
- Contact the study coordinator or principal investigator to ask for pre-screening. Pre-screening is free and never obligates you to enroll.